| Mr Michael Thomas Ammann, DO | |
|
1055 E La Canada, Ste 135, Green Valley, AZ 85614 | |
| (520) 625-3230 | |
| (520) 625-9162 |
| Full Name | Mr Michael Thomas Ammann |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 1055 E La Canada, Ste 135, Green Valley, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932264843 | NPI | - | NPPES |
| 485767 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2536 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tucson Medical Center | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Community Physicians Pc | 4587560552 | 158 |
News Archive
Celgene Corporation announced the Company's Board of Directors has authorized the repurchase of up to an additional $2 billion of the Company's common stock.
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
PositiveID Corporation announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office covering the interface between a radio frequency ("RF") powered resonant electromechanical drive and the fluids in the interstitial space of a patient for continuous detection of glucose levels in a patient. The interface employs a resonant electromechanical drive for mass sensing and RF communication of glucose levels.
A researcher at the IMT School for Advanced Studies Lucca, Giulio Bernardi, has been awarded a European Research Council Starting grant, a competitive source of financing attributed to young researchers who pursue innovative research ideas.
› Verified 9 days ago
| Entity Name | Arizona Community Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205871076 PECOS PAC ID: 4587560552 Enrollment ID: O20031210000500 |
News Archive
Celgene Corporation announced the Company's Board of Directors has authorized the repurchase of up to an additional $2 billion of the Company's common stock.
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
PositiveID Corporation announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office covering the interface between a radio frequency ("RF") powered resonant electromechanical drive and the fluids in the interstitial space of a patient for continuous detection of glucose levels in a patient. The interface employs a resonant electromechanical drive for mass sensing and RF communication of glucose levels.
A researcher at the IMT School for Advanced Studies Lucca, Giulio Bernardi, has been awarded a European Research Council Starting grant, a competitive source of financing attributed to young researchers who pursue innovative research ideas.
› Verified 9 days ago
| Entity Name | Nextcare Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043371826 PECOS PAC ID: 9537161260 Enrollment ID: O20070209000357 |
News Archive
Celgene Corporation announced the Company's Board of Directors has authorized the repurchase of up to an additional $2 billion of the Company's common stock.
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
PositiveID Corporation announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office covering the interface between a radio frequency ("RF") powered resonant electromechanical drive and the fluids in the interstitial space of a patient for continuous detection of glucose levels in a patient. The interface employs a resonant electromechanical drive for mass sensing and RF communication of glucose levels.
A researcher at the IMT School for Advanced Studies Lucca, Giulio Bernardi, has been awarded a European Research Council Starting grant, a competitive source of financing attributed to young researchers who pursue innovative research ideas.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Thomas Ammann, DO 5055 E Broadway Blvd, Ste A100, Tucson, AZ 85711 Ph: (520) 382-1205 | Mr Michael Thomas Ammann, DO 1055 E La Canada, Ste 135, Green Valley, AZ 85614 Ph: (520) 625-3230 |
News Archive
Celgene Corporation announced the Company's Board of Directors has authorized the repurchase of up to an additional $2 billion of the Company's common stock.
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
PositiveID Corporation announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office covering the interface between a radio frequency ("RF") powered resonant electromechanical drive and the fluids in the interstitial space of a patient for continuous detection of glucose levels in a patient. The interface employs a resonant electromechanical drive for mass sensing and RF communication of glucose levels.
A researcher at the IMT School for Advanced Studies Lucca, Giulio Bernardi, has been awarded a European Research Council Starting grant, a competitive source of financing attributed to young researchers who pursue innovative research ideas.
› Verified 9 days ago
Rodolfo Jimenez, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1260 S Campbell Rd, Green Valley, AZ 85614 Phone: 520-625-3691 Fax: 520-625-2894 | |
Dr. Amy Jean Rosenberg, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1260 S Campbell Ave, Building 2, Green Valley, AZ 85614 Phone: 520-407-5400 Fax: 520-407-5990 | |
Marie Benitez, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1260 S Campbell Rd, Green Valley, AZ 85614 Phone: 520-625-3691 Fax: 520-625-2894 | |
Jimmy Dean Emery, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2475 E Glen Canyon Rd, Green Valley, AZ 85614 Phone: 520-398-6861 Fax: 520-398-6861 | |
Diane C Downing, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 W Continental Rd, Ste 141, Green Valley, AZ 85614 Phone: 520-625-3691 Fax: 520-547-3994 | |
Dr. Edward John Holubowitch, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 400 W Camino Casa Verde, #100, Green Valley, AZ 85614 Phone: 520-625-1760 Fax: 520-648-1394 | |
Dr. Laura S Brown, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 W Camino Casa Verde, Suite 100, Green Valley, AZ 85614 Phone: 520-625-1760 Fax: 520-648-1394 |